133 related articles for article (PubMed ID: 24332783)
1. Induction of mandibular tremor using electrolytic lesion of the ventrolateral striatum or using subchronic haloperidol therapy in male rats: an electromyographic comparison.
Herrera-Meza G; Manzo J; Hernández ME; Miquel M; García LI
Neurologia; 2014 Sep; 29(7):416-22. PubMed ID: 24332783
[TBL] [Abstract][Full Text] [Related]
2. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
Podurgiel SJ; Nunes EJ; Yohn SE; Barber J; Thompson A; Milligan M; Lee CA; López-Cruz L; Pardo M; Valverde O; Lendent C; Baqi Y; Müller CE; Correa M; Salamone JD
Neuroscience; 2013 Oct; 250():507-19. PubMed ID: 23867769
[TBL] [Abstract][Full Text] [Related]
3. Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation.
Collins-Praino LE; Podurgiel SJ; Kovner R; Randall PA; Salamone JD
Behav Brain Res; 2012 Sep; 234(1):129-35. PubMed ID: 22728308
[TBL] [Abstract][Full Text] [Related]
4. Pramipexole reduces parkinsonian tremor induced by pilocarpine infusion in the rat striatum.
Yasuda K; Abe H; Koganemaru G; Ikeda T; Arimori K; Ishida Y
Pharmacol Biochem Behav; 2015 Apr; 131():1-5. PubMed ID: 25622778
[TBL] [Abstract][Full Text] [Related]
5. Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats.
Ishiwari K; Betz A; Weber S; Felsted J; Salamone JD
Pharmacol Biochem Behav; 2005 Feb; 80(2):351-62. PubMed ID: 15680188
[TBL] [Abstract][Full Text] [Related]
6. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.
Betz AJ; Vontell R; Valenta J; Worden L; Sink KS; Font L; Correa M; Sager TN; Salamone JD
Neuroscience; 2009 Sep; 163(1):97-108. PubMed ID: 19467297
[TBL] [Abstract][Full Text] [Related]
7. The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism.
Correa M; Wisniecki A; Betz A; Dobson DR; O'Neill MF; O'Neill MJ; Salamone JD
Behav Brain Res; 2004 Jan; 148(1-2):47-54. PubMed ID: 14684247
[TBL] [Abstract][Full Text] [Related]
8. Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions.
Simola N; Fenu S; Baraldi PG; Tabrizi MA; Morelli M
Exp Neurol; 2004 Sep; 189(1):182-8. PubMed ID: 15296848
[TBL] [Abstract][Full Text] [Related]
9. Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.
Collins LE; Paul NE; Abbas SF; Leser CE; Podurgiel SJ; Galtieri DJ; Chrobak JJ; Baqi Y; Müller CE; Salamone JD
Pharmacol Biochem Behav; 2011 Sep; 99(3):414-22. PubMed ID: 21640750
[TBL] [Abstract][Full Text] [Related]
10. Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor.
Carlson BB; Wisniecki A; Salamone JD
Psychopharmacology (Berl); 2003 Jan; 165(3):229-37. PubMed ID: 12420151
[TBL] [Abstract][Full Text] [Related]
11. Motor effects of GABA(A) antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats.
Wisniecki A; Correa M; Arizzi MN; Ishiwari K; Salamone JD
Psychopharmacology (Berl); 2003 Nov; 170(2):140-9. PubMed ID: 12827348
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of adenosine antagonists in two models of parkinsonian tremor.
Trevitt J; Kawa K; Jalali A; Larsen C
Pharmacol Biochem Behav; 2009 Nov; 94(1):24-9. PubMed ID: 19602422
[TBL] [Abstract][Full Text] [Related]
13. Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism.
Podurgiel SJ; Spencer T; Kovner R; Baqi Y; Müller CE; Correa M; Salamone JD
Pharmacol Biochem Behav; 2016 Jan; 140():62-7. PubMed ID: 26459156
[TBL] [Abstract][Full Text] [Related]
14. Blockade of adenosine A
Kosmowska B; Ossowska K; Wardas J
Behav Brain Res; 2022 Jan; 417():113585. PubMed ID: 34536428
[TBL] [Abstract][Full Text] [Related]
15. Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor.
Podurgiel S; Collins-Praino LE; Yohn S; Randall PA; Roach A; Lobianco C; Salamone JD
Pharmacol Biochem Behav; 2013 Apr; 105():105-11. PubMed ID: 23360954
[TBL] [Abstract][Full Text] [Related]
16. Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism.
Collins-Praino LE; Paul NE; Ledgard F; Podurgiel SJ; Kovner R; Baqi Y; Müller CE; Senatus PB; Salamone JD
Eur J Neurosci; 2013 Jul; 38(1):2183-91. PubMed ID: 23600953
[TBL] [Abstract][Full Text] [Related]
17. Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease.
Simola N; Fenu S; Baraldi PG; Tabrizi MA; Morelli M
J Neurol Sci; 2006 Oct; 248(1-2):48-52. PubMed ID: 16780890
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment.
Roberts RC; Force M; Kung L
Synapse; 2002 Aug; 45(2):78-85. PubMed ID: 12112400
[TBL] [Abstract][Full Text] [Related]
19. Effects of zonisamide on c-Fos expression under conditions of tacrine-induced tremulous jaw movements in rats: a potential mechanism underlying its anti-parkinsonian tremor effect.
Miwa H; Kubo T; Suzuki A; Kondo T
Parkinsonism Relat Disord; 2009 Jan; 15(1):30-5. PubMed ID: 18693129
[TBL] [Abstract][Full Text] [Related]
20. Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor.
Salamone JD; Collins-Praino LE; Pardo M; Podurgiel SJ; Baqi Y; Müller CE; Schwarzschild MA; Correa M
Eur Neuropsychopharmacol; 2013 Aug; 23(8):972-7. PubMed ID: 22947264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
